Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

The BEACON study used de-identified data from the Tempus Database, assessing IB6 expression via immunohistochemistry.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients' out-of-whack immune ...

Pove was generally safe and well tolerated with adverse events (AEs) that were mostly mild or moderate in severity. There were no serious adverse events related to povetacicept. The safety data is ...

Operator: Welcome to Tivic Health Systems third quarter 2025 financial results and operational update conference call. This ...

Scientists have recovered RNA from a mammoth carcass preserved in permafrost for 40,000 years. The ancient molecules reveal ...

Scientists discover a new gene therapy technique that may reverse ALS by restoring vital RNA signals, providing hope for ...

The Coronado Unified School District is poised to take a critical look at its current cell phone policy at all four of its ...

MIAMI, FL / ACCESS Newswire / November 12, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held biotechnology company focused on the development of innovative ...

Stress can accelerate the depletion of pigment-producing cell progenitors, which is a natural aging process. But this may be ...

Yes, mayonnaise makes a great sandwich spread, but it can do so much more. Try these 13 creative uses, and be amazed by the ...

SynchNeuro is a Portfolio Company of Boomerang Ventures INDIANAPOLIS, IN / ACCESS Newswire / November 12, 2025 / Boomerang Ventures adds SynchNeuro, Inc. to its portfolio of seed-stage investments, ...